Five biotech companies that are nearing a crucial crossroad in the next two or three months. Each of them face a moment of truth that has been years in the making. This is how Liang and Schwartz of Leerink Swann see the chips falling in the weeks and months to come for Human Genome Sciences, Auxilium Pharmaceuticals, Inspire Pharmaceuticals, GTx and Poniard Pharmaceuticals. Stock report